Literature DB >> 3275473

Relationship between an activated N-ras oncogene and chromosomal abnormality during leukemic progression from myelodysplastic syndrome.

H Hirai1, M Okada, H Mizoguchi, H Mano, Y Kobayashi, J Nishida, F Takaku.   

Abstract

The relationship between chromosomal abnormality and oncogene activation was investigated during leukemic progression in two patients with myelodysplastic syndrome (MDS). Both patients had partial or complete deletion of chromosome 5 in metaphase cells obtained throughout the progression to leukemia. Analysis with specific oligonucleotide probes revealed that bone marrow cells containing an activated N-ras oncogene proliferated in a dominant manner during the process of leukemic conversion in both patients. These observations suggest that the chromosomal abnormality may precede activation of the N-ras gene in these patients, and that both the chromosomal abnormality and the activated N-ras oncogene contribute to the development of leukemia.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3275473

Source DB:  PubMed          Journal:  Blood        ISSN: 0006-4971            Impact factor:   22.113


  7 in total

1.  Oncogenicity of human N-ras oncogene and proto-oncogene introduced into retroviral vectors.

Authors:  M Souyri; I Vigon; M Charon; P Tambourin
Journal:  J Virol       Date:  1989-09       Impact factor: 5.103

Review 2.  Myelodysplastic syndromes.

Authors:  D C Doll; A F List
Journal:  West J Med       Date:  1989-08

3.  Prevalence and clinical implications of NRAS mutations in childhood AML: a report from the Children's Oncology Group.

Authors:  J N Berman; R B Gerbing; T A Alonzo; P A Ho; K Miller; C Hurwitz; N A Heerema; B Hirsch; S C Raimondi; B Lange; J L Franklin; A Gamis; S Meshinchi
Journal:  Leukemia       Date:  2011-03-01       Impact factor: 11.528

Review 4.  Molecular pathogenesis of MDS.

Authors:  Hisamaru Hirai
Journal:  Int J Hematol       Date:  2002-08       Impact factor: 2.490

Review 5.  FAB classification of myelodysplastic syndromes: merits and controversies.

Authors:  G E Verhoef; S Pittaluga; C De Wolf-Peeters; M A Boogaerts
Journal:  Ann Hematol       Date:  1995-07       Impact factor: 3.673

Review 6.  The process of leukemogenesis.

Authors:  R D Irons; W S Stillman
Journal:  Environ Health Perspect       Date:  1996-12       Impact factor: 9.031

7.  Ras oncogene expression and DNA content in plasma cell dyscrasias: a flow cytofluorimetric study.

Authors:  M Danova; A Riccardi; G Ucci; R Luoni; M Giordano; G Mazzini
Journal:  Br J Cancer       Date:  1990-11       Impact factor: 7.640

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.